Search results (728)
« Back to PublicationsComorbidities, medication use, and overall survival in eight cancers: a multinational cohort study of 1.7 million patients across Europe.
Journal article
López-Sánchez I. et al, (2026), Lancet Reg Health Eur, 63
Incidence and survival of head and neck cancers in the United Kingdom 2000-2021.
Journal article
Miquel-Dominguez A. et al, (2026), Cancer Epidemiol, 101
Incidence and Survival of Colorectal Cancer in the United Kingdom From 2000 to 2021: A Population-Based Cohort Study.
Journal article
Pedregal-Pascual P. et al, (2025), Am J Gastroenterol, 120, 2909 - 2917
Phosphodiesterase-5 Inhibition and Alzheimer's Disease Risk: A Mendelian Randomisation Study.
Journal article
Alcalde-Herraiz M. et al, (2025), Aging Cell, 24
The use of antibiotics commonly associated with antimicrobial resistance: a UK network cohort study using primary and hospital care data
Preprint
Rowlands E. et al, (2025)
CohortSymmetry: An R package to perform sequence symmetry analysis using the OMOP common data model
Preprint
Chen X. et al, (2025)
Trends in incidence, prevalence, and survival of primary liver cancer in the United Kingdom (2000-2021).
Journal article
Cuyàs B. et al, (2025), Eur J Public Health
The relationship between anaemia, haemoglobin levels, and cognitive function: Evidence in two population-based cohorts from India and the United States.
Journal article
Winchester LM. et al, (2025), Neurobiol Dis, 216
Prescription Cascades Associated with Acetylcholinesterase Inhibitors Use: A High-Throughput Sequence Symmetry Analysis
Preprint
Newby D. et al, (2025)
Incidence and Survival of Head and Neck Cancers in the United Kingdom 2000-2021
Preprint
Dominguez AM. et al, (2024)
Genome-wide association neural networks identify genes linked to family history of Alzheimer's disease.
Journal article
Ghose U. et al, (2024), Brief Bioinform, 26
Drug target Mendelian randomisation vs. propensity score weighting for causal inference: estimating vaccine-induced antibody effect on COVID-19 outcomes
Conference paper
Xie J. et al, (2024), Pharmacoepidemiology and Drug Safety, 33
PDE5 inhibition and Alzheimer’s disease risk: a mendelian randomisation study
Preprint
Alcalde-Herraiz M. et al, (2024)